P

PharmaResearch Co Ltd
KOSDAQ:214450

Watchlist Manager
PharmaResearch Co Ltd
KOSDAQ:214450
Watchlist
Price: 198 400 KRW -0.8% Market Closed
Market Cap: 2.1T KRW
Have any thoughts about
PharmaResearch Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
PharmaResearch Co Ltd

Wall Street analysts forecast PharmaResearch Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PharmaResearch Co Ltd is 276 857.14 KRW with a low forecast of 232 300 KRW and a high forecast of 315 000 KRW.

Lowest
Price Target
232 300 KRW
17% Upside
Average
Price Target
276 857.14 KRW
40% Upside
Highest
Price Target
315 000 KRW
59% Upside
PharmaResearch Co Ltd Competitors:
Price Targets
DNLI
Denali Therapeutics Inc
76% Upside
NTRA
Natera Inc
4% Upside
IONS
Ionis Pharmaceuticals Inc
81% Upside
SPRY
ARS Pharmaceuticals Inc
108% Upside
2162
KeyMed Biosciences Inc
60% Upside
DVYSR
Devyser Diagnostics AB
14% Upside
BIOPOR
Bioporto A/S
88% Upside
358570
GI Innovation Inc
154% Upside

Revenue
Forecast

Revenue Estimate
PharmaResearch Co Ltd

For the last 8 years the compound annual growth rate for PharmaResearch Co Ltd's revenue is 27%. The projected CAGR for the next 3 years is 23%.

27%
Past Growth
23%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
PharmaResearch Co Ltd

For the last 8 years the compound annual growth rate for PharmaResearch Co Ltd's operating income is 24%. The projected CAGR for the next 3 years is 26%.

24%
Past Growth
26%
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

Net Income Estimate
PharmaResearch Co Ltd

For the last 8 years the compound annual growth rate for PharmaResearch Co Ltd's net income is 25%. The projected CAGR for the next 3 years is 25%.

25%
Past Growth
25%
Estimated Growth
Estimates Accuracy
-18%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PharmaResearch Co Ltd's stock price target?
Price Target
276 857.14 KRW

According to Wall Street analysts, the average 1-year price target for PharmaResearch Co Ltd is 276 857.14 KRW with a low forecast of 232 300 KRW and a high forecast of 315 000 KRW.

What is PharmaResearch Co Ltd's Revenue forecast?
Projected CAGR
23%

For the last 8 years the compound annual growth rate for PharmaResearch Co Ltd's revenue is 27%. The projected CAGR for the next 3 years is 23%.

What is PharmaResearch Co Ltd's Operating Income forecast?
Projected CAGR
26%

For the last 8 years the compound annual growth rate for PharmaResearch Co Ltd's operating income is 24%. The projected CAGR for the next 3 years is 26%.

What is PharmaResearch Co Ltd's Net Income forecast?
Projected CAGR
25%

For the last 8 years the compound annual growth rate for PharmaResearch Co Ltd's net income is 25%. The projected CAGR for the next 3 years is 25%.

Back to Top